pharma
AstraZeneca chalks up double Japanese approval in lung and breast cancer
July 2, 2018Sales and Marketing AstraZeneca, Cancer, Imfinzi, NSCLD, breast cancer, lung cancer, lynparza, pharma
It’s a big step forward for AstraZeneca’s global marketing operations as the company announced that two of its products have …
Takeda’s Entyvio secures Japanese approval in ulcerative colitis
July 2, 2018Sales and Marketing Entyvio, Japan, Takeda, pharma, ulcerative colitis
Takeda Pharmaceutical has announced that its monoclonal antibody, Entyvio (vedolizumab), has been approved for the treatment of patients with moderately …
AbbVie ordered to pay $448m over generic delays
July 2, 2018Sales and Marketing AbbVie, FTC, androgel, besins, branded generics, pharma
A US Judge has ordered pharmaceutical company AbbVie to pay $448 million after determining that the company had used sham …
Top Ten most popular articles on Pharmafile.com this week
June 29, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HIV, J&J, JJ, Remicade, Roche, biosimilar Amgen, lung cancer, multiple sclerosis, pharma
Summer seems to be in full swing as we reach the end of June, so it’s time to look back …
Novartis spins off Alcon as CEO focuses drug search
June 29, 2018Medical Communications, Sales and Marketing Alcon, Novartis, eye care, pharma
Novartis has announced a plan to spinoff Alcon – its eye care division – into a separately-traded standalone company.Novartis has …
Pfizer’s Xeljanz scores EU approval for active psoriatic arthritis
June 29, 2018Medical Communications, Sales and Marketing EU, Europe, Pfizer, Xeljanz, pharma, psoriatic arthritis
Pfizer has announced that the European Commission (EC) has approved Xeljanz in combination with methotrexate (MTX) for the treatment of …
NICE turns down Roche’s Ocrevus in early primary progressive multiple sclerosis
June 29, 2018Medical Communications, Sales and Marketing NICE, Ocrevus, Roche, pharma
Roche’s sometimes strained relationship with NICE continues as the health watchdog for England and Wales chose to reject the former’s …
Amazon makes first move into healthcare with online pharmacy acquisition
June 28, 2018Medical Communications, Sales and Marketing amazon, pharma, pharmacy
It’s been thought to have been on the cards for some time, but now, after much speculation, retail giant Amazon …
Ferring’s heat-stable drug could stop post-childbirth bleeding, WHO says
June 28, 2018Research and Development Carbetocin, Ferring Pharmaceuticals, MSD, WHO, childbirth, pharma
A new formulation of a drug to prevent excessive bleeding in women after childbirth could save thousands of lives, says …
Centralised EMR systems drive patient-physician relationships, report indicates
June 28, 2018Medical Communications, Research and Development Electronic Medical Records, pharma
Advancement of IT within healthcare is transforming the dynamics of the patient-physician relationship and it is important to integrate various …
Summit Pharma axes Duchenne drug after Phase 2 failures
June 28, 2018Research and Development Duchenne Muscular Dystrophy, Summit Pharmaceuticals, pharma, trial failure
Summit Therapeutics has revealed it is to terminate development of its Duchenne muscular dystrophy (DMD) drug ezutromid after it failed …
Roche’s Alecensa secures NICE approval in NSCLC after topping Pfizer’s Xalkori
June 28, 2018Sales and Marketing Alecensa, NICE, NSCLC, Pfizer, Xalkori, pharma
UK health watchdog NICE has given its approval for Roche’s selective ALK inhibitor Alecensa (alectinib) for use on the NHS, …
Amgen biosimilar proves non-inferior to J&J’s Remicade in rheumatoid arthritis
June 27, 2018Research and Development, Sales and Marketing Amgen, Johnson & Jonson, Remicade, pharma, rheumatoid arthritis
Amgen has unveiled new Phase 3 data for its biosimilar version of Johnson & Johnson’s Remicade (infliximab), confirming that it …
US hospital’s ketamine study forced to a halt over consent concerns
June 27, 2018Research and Development Hennepin Healthcare, Ketamine, pharma
Minneapolis-based hospital Hennepin County Medical Center has put the brakes on a clinical trial investigating the efficacy of ketamine in …
Abbvie and Google’s Calico extend age-related disease partnership to $2.5bn
June 27, 2018Research and Development, Sales and Marketing AbbVie, Cancer, Goggle, calico, pharma
The partnership of Abbvie and Google’s Calico has announced they are to extend their existing 10-year drug discovery and development …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
